Literature DB >> 2409203

Pili of Neisseria meningitidis. Analysis of structure and investigation of structural and antigenic relationships to gonococcal pili.

D S Stephens, A M Whitney, J Rothbard, G K Schoolnik.   

Abstract

To provide information useful for the design of a pilus vaccine effective for the prevention of both meningococcal and gonococcal disease, the electron microscopic morphology of meningococcal pili and the structural and antigenic relationships of meningococcal pili to gonococcal pili were investigated. Meningococcal pili were 4-6 nm in width, extended 500-6,000 nm from the organism surface, and occurred singly or in bundles composed of 8-10 pili per bundle. Meningococcal pilin varied between 17,250 and 20,600 daltons. Pilin was present in outer membrane preparations of some meningococcal isolates that were nonpiliated by electron microscopic examination. Antibodies to gonococcal pili, cyanogen bromide cleavage fragments of gonococcal pilin, or synthetic peptide analogues corresponding to regions of the gonococcal pilin sequence, were used to detect common meningococcal and gonococcal antigenic determinants that might indicate the existence of a conserved sequence beyond residue 29. Antibody to intact gonococcal pili or to the variable CNBR-3 region of gonococcal pilin detected little shared antigenicity with meningococcal pilin. However, pilin from all tested meningococcal isolates reacted with antibody to the CNBR-2 fragment of gonococcal pilin, a region highly conserved among gonococcal strains. Meningococcal pilins were also broadly crossreactive with antibody to a synthetic peptide corresponding to residues 69-84 of the gonococcal sequence, a part of the CNBR-2 region that appears to be critical for gonococcal receptor-binding function. If a sequence similar to 69-84 is also important for receptor-binding function in meningococcal pili, a peptide corresponding to this region may elicit antibodies that block the adherence function of pili elaborated by both Neisseria gonorrhoeae and N. meningitidis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409203      PMCID: PMC2187639          DOI: 10.1084/jem.161.6.1539

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  37 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Protection against enteric disease caused by Escherichia coli--a model for vaccination with a virulence determinant?

Authors:  J M Rutter; G W Jones
Journal:  Nature       Date:  1973-04-20       Impact factor: 49.962

3.  Piliation of gonococci in vivo.

Authors:  J F James; J Swanson
Journal:  J Infect Dis       Date:  1978-01       Impact factor: 5.226

4.  Deoxyribonucleic acid homologies among species of the genus Neisseria.

Authors:  D T Kingsbury
Journal:  J Bacteriol       Date:  1967-10       Impact factor: 3.490

Review 5.  The structure, function, synthesis and genetic control of bacterial pili and a molecular model for DNA and RNA transport in gram negative bacteria.

Authors:  C C Brinton
Journal:  Trans N Y Acad Sci       Date:  1965-06

6.  Attachment and ingestion of gonococci human neutrophils.

Authors:  J A Dilworth; J O Hendley; G L Mandell
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

7.  Attachment role of gonococcal pili. Optimum conditions and quantitation of adherence of isolated pili to human cells in vitro.

Authors:  W A Pearce; T M Buchanan
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

8.  Pili of Neisseria meningitidis: effect of media on maintenance of piliation, characteristics of Pili, and colonial morphology.

Authors:  Z A McGee; C H Street; C L Chappell; E S Cousar; F Morris; R G Horn
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

9.  Neisseria pili proteins: amino-terminal amino acid sequences and identification of an unusual amino acid.

Authors:  M A Hermodson; K C Chen; T M Buchanan
Journal:  Biochemistry       Date:  1978-02-07       Impact factor: 3.162

10.  Antigenic heterogeneity of gonococcal pili.

Authors:  T M Buchanan
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

View more
  23 in total

1.  Polymorphisms in pilin glycosylation Locus of Neisseria meningitidis expressing class II pili.

Authors:  C M Kahler; L E Martin; Y L Tzeng; Y K Miller; K Sharkey; D S Stephens; J K Davies
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  Frequency and rate of pilin antigenic variation of Neisseria meningitidis.

Authors:  R Allen Helm; H Steven Seifert
Journal:  J Bacteriol       Date:  2010-05-14       Impact factor: 3.490

3.  Discovery of a novel protein modification: alpha-glycerophosphate is a substituent of meningococcal pilin.

Authors:  E Stimson; M Virji; S Barker; M Panico; I Blench; J Saunders; G Payne; E R Moxon; A Dell; H R Morris
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

4.  Morphological differences in Neisseria meningitidis pili.

Authors:  J J Greenblatt; K Floyd; M E Philipps; C E Frasch
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

Review 5.  Structure and function of pili of pathogenic Neisseria species.

Authors:  J E Heckels
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

Review 6.  Type IV pilin proteins: versatile molecular modules.

Authors:  Carmen L Giltner; Ylan Nguyen; Lori L Burrows
Journal:  Microbiol Mol Biol Rev       Date:  2012-12       Impact factor: 11.056

7.  Variation in the structural subunit and basal protein antigens of Bacteroides nodosus fimbriae.

Authors:  B J Anderson; C L Kristo; J R Egerton; J S Mattick
Journal:  J Bacteriol       Date:  1986-05       Impact factor: 3.490

8.  Analysis of damage to human ciliated nasopharyngeal epithelium by Neisseria meningitidis.

Authors:  D S Stephens; A M Whitney; M A Melly; L H Hoffman; M M Farley; C E Frasch
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

Review 9.  Meningococcal vaccines.

Authors:  Jens U Rüggeberg; Andrew J Pollard
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

10.  Pathogenesis, Therapy, and Prevention of Meningococcal Sepsis.

Authors:  David S. Stephens; Shanta M. Zimmer
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.